BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27289045)

  • 21. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
    Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
    Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor-α36 is involved in diallyl sulfide-induced inhibition of malignant growth of HepG2 and Huh7 hepatocellular carcinoma cells.
    Wu W; Chen H; Wang R; Chen J; Yu H; Wei Z; Liu X; Xue M; Chen Q; Zhou H; Fu Z
    Environ Toxicol; 2022 Feb; 37(2):270-281. PubMed ID: 34724321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.
    Liu K; Lin D; Ouyang Y; Pang L; Guo X; Wang S; Zang Y; Chen D
    Tumour Biol; 2017 Mar; 39(3):1010428317695026. PubMed ID: 28351301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
    Wang T; Qin ZY; Wen LZ; Guo Y; Liu Q; Lei ZJ; Pan W; Liu KJ; Wang XW; Lai SJ; Sun WJ; Wei YL; Liu L; Guo L; Chen YQ; Wang J; Xiao HL; Bian XW; Chen DF; Wang B
    Cell Death Differ; 2018 Dec; 25(12):2086-2100. PubMed ID: 29555977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation.
    Lin HH; Peng YJ; Tsai MJ; Wu YY; Tsai TN; Huang HH; Shih YL; Chang WK; Hsieh TY
    J Cell Physiol; 2020 Feb; 235(2):1689-1699. PubMed ID: 31298420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
    Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
    Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hepatocellular carcinoma by fulvestrant involves the estrogen receptor α and Wnt pathways in vitro and in patients.
    Wang CJ; Guo DK; You TG; Shen DW; Wang C; Tang L; Wang J; Xu RH; Zhang H
    Mol Med Rep; 2014 Dec; 10(6):3125-31. PubMed ID: 25270093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.
    Teng Y; Radde BN; Litchfield LM; Ivanova MM; Prough RA; Clark BJ; Doll MA; Hein DW; Klinge CM
    J Biol Chem; 2015 Jun; 290(25):15799-15811. PubMed ID: 25969534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
    Wang J; Gildea JJ; Yue W
    Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
    Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
    Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells.
    You H; Meng K; Wang ZY
    Steroids; 2018 Jun; 134():78-87. PubMed ID: 29481815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
    Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
    Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.
    Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
    Chettouh H; Fartoux L; Aoudjehane L; Wendum D; Clapéron A; Chrétien Y; Rey C; Scatton O; Soubrane O; Conti F; Praz F; Housset C; Rosmorduc O; Desbois-Mouthon C
    Cancer Res; 2013 Jul; 73(13):3974-86. PubMed ID: 23633480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytoestrogens Activate the Estrogen Receptor in HepG2 Cells.
    Kelly LA
    Methods Mol Biol; 2016; 1366():445-455. PubMed ID: 26585156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.